Autologous PEP-DC Vaccine（Centre Hospitalier Universitaire Vaudois）

Product Name :
Autologous PEP-DC Vaccine（Centre Hospitalier Universitaire Vaudois）

Search keywords :
DC1

drugId :
null

Target Vo:
Not applicable

Target Vo Short Name :
Not applicable

Moa_Name:
Immunostimulants

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Centre Hospitalier Universitaire Vaudois

Active Company_Name :
Centre Hospitalier Universitaire Vaudois

Active Indication_Name:
Carcinoma, Ovarian Epithelial

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Hsp40 Antibody
Ubiquitin Antibody
mTOR Antibody: mTOR Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 289 kDa, targeting to mTOR. It can be used for WB,IHC-P,ICC/IF,IP,FC assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts